Shulin Xu
About
In The Last Decade
Shulin Xu
18 papers receiving 339 citations
Peers
Comparison fields: 5 of 62
- Immunology 173
- Molecular Biology 70
- Public Health, Environmental and Occupational Health 65
- Oncology 63
- Insect Science 52
Countries citing papers authored by Shulin Xu
This map shows the geographic impact of Shulin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulin Xu more than expected).
Fields of papers citing papers by Shulin Xu
This network shows the impact of papers produced by Shulin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulin Xu. The network helps show where Shulin Xu may publish in the future.
Co-authorship network of co-authors of Shulin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shulin Xu. A scholar is included among the top collaborators of Shulin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shulin Xu. Shulin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 39 | |
| 5 | 5 | |
| 6 | 19 | |
| 7 | 38 | |
| 8 | 12 | |
| 9 | 15 | |
| 10 | 8 | |
| 11 | 23 | |
| 12 | 16 | |
| 13 | 10 | |
| 14 | 30 | |
| 15 | Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity. | 66 |
| 16 | Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation. | 21 |
| 17 | 22 | |
| 18 | Increased susceptibility of tumorigenicity and decreased anti-tumor effect of DC vaccination in aged mice are potentially associated with increased number of NK1.1+CD3+ NKT cells. | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.